Improving the predictive potential of diffusion MRI in schizophrenia using normative models-Towards subject-level classification.

Journal: Human brain mapping
Published Date:

Abstract

Diffusion MRI studies consistently report group differences in white matter between individuals diagnosed with schizophrenia and healthy controls. Nevertheless, the abnormalities found at the group-level are often not observed at the individual level. Among the different approaches aiming to study white matter abnormalities at the subject level, normative modeling analysis takes a step towards subject-level predictions by identifying affected brain locations in individual subjects based on extreme deviations from a normative range. Here, we leveraged a large harmonized diffusion MRI dataset from 512 healthy controls and 601 individuals diagnosed with schizophrenia, to study whether normative modeling can improve subject-level predictions from a binary classifier. To this aim, individual deviations from a normative model of standard (fractional anisotropy) and advanced (free-water) dMRI measures, were calculated by means of age and sex-adjusted z-scores relative to control data, in 18 white matter regions. Even though larger effect sizes are found when testing for group differences in z-scores than are found with raw values (p < .001), predictions based on summary z-score measures achieved low predictive power (AUC < 0.63). Instead, we find that combining information from the different white matter tracts, while using multiple imaging measures simultaneously, improves prediction performance (the best predictor achieved AUC = 0.726). Our findings suggest that extreme deviations from a normative model are not optimal features for prediction. However, including the complete distribution of deviations across multiple imaging measures improves prediction, and could aid in subject-level classification.

Authors

  • Doron Elad
    Department of Mathematics, Tel-Aviv University, Tel-Aviv, Israel.
  • Suheyla Cetin-Karayumak
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Fan Zhang
    Department of Anesthesiology, Bishan Hospital of Chongqing Medical University, Chongqing, China.
  • Kang Ik K Cho
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Amanda E Lyall
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Johanna Seitz-Holland
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Rami Ben-Ari
    IBM Research Haifa, Haifa University Campus, Mount Carmel, Haifa, Israel.
  • Godfrey D Pearlson
    Olin Neuropsychiatry Research Center, Hartford Hospital (IOL Campus), Hartford, CT, USA; Department of Psychiatry and Neurobiology, Yale University School of Medicine, New Haven, CT, USA.
  • Carol A Tamminga
    Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • John A Sweeney
    Department of Radiology, the Center for Medical Imaging, West China Hospital of Sichuan University, China; Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati, USA.
  • Brett A Clementz
    Department of Psychology, University of Georgia, Athens, Georgia.
  • David J Schretlen
    Department of Psychiatry and Behavioral Sciences, Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
  • Petra Verena Viher
    Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, Switzerland.
  • Katharina Stegmayer
    Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, Switzerland.
  • Sebastian Walther
    Translational Research Center, University Hospital of Psychiatry, University of Bern, Bern, Switzerland.
  • Jungsun Lee
    Department of Psychiatry, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Tim J Crow
    Department of Psychiatry, SANE POWIC, Warneford Hospital, University of Oxford, Oxford, UK.
  • Anthony James
    University of Oxford, Oxford, United Kingdom.
  • Aristotle N Voineskos
    Kimel Family Translational Imaging-Genetics Research Lab, Research Imaging Centre, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Geriatric Mental Health Division, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada.
  • Robert W Buchanan
    Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Philip R Szeszko
    Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Anil K Malhotra
    The Feinstein Institute for Medical Research and Zucker Hillside Hospital, Manhasset, New York, USA.
  • Matcheri S Keshavan
    BethIsrael Deaconess Medical Center, United States; Harvard Medical School, United States. Electronic address: mkeshava@bidmc.harvard.edu.
  • Martha E Shenton
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Yogesh Rathi
    Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
  • Sylvain Bouix
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Nir Sochen
    Department of Mathematics, Tel-Aviv University, Tel-Aviv, Israel.
  • Marek R Kubicki
    Department of Psychiatry, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Ofer Pasternak
    Departments of Psychiatry and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.